• For Researchers

A bug in the system – the difficulties of linking the microbiome to cancer aetiology

Teasing apart causation from correlation is vital if we are to understand whether the gut microbiome changes the risk of cancer or whether cancer changes the gut microbiome. Teasing apart causation from correlation is vital if we are to understand whether the gut microbiome changes the risk of cancer or whether cancer changes the gut microbiome.

2 June 2021

• For Supporters

Partnership in a pandemic: how Credit Suisse delivered an incredible Charity of the Year partnership despite lockdown

We explore how our partner, Credit Suisse, adapted to significant changes in the fundraising environment to exceed its original targets for the partnership. We explore how our partner, Credit Suisse, adapted to significant changes in the fundraising environment to exceed its original targets for the partnership.

20 May 2021

• For Researchers

Cancer clinical trials – learning lessons from the COVID-19 pandemic

After a very difficult year for cancer clinical trials, we look to the future and ask what positive lessons can be learnt After a very difficult year for cancer clinical trials, we look to the future and ask what positive lessons can be learnt

20 May 2021

• For Supporters

Peer-to-peer match-funding initiative raises over £4 million for cancer research

The Cancer Research UK Challenge Fund, which we launched in the initial throes of the pandemic, will help to ensure we can continue funding vital research. The Cancer Research UK Challenge Fund, which we launched in the initial throes of the pandemic, will help to ensure we can continue funding vital research.

19 May 2021

• For Supporters

Catch up on Behind the Science 2021 – From funding stream to blood stream: Is drug development moving fast enough?

This year’s event took place virtually on Wednesday 12 May. Watch or listen back now. This year’s event took place virtually on Wednesday 12 May. Watch or listen back now.

18 May 2021

• Health & Medicine

Cancer Research UK spin-out goes public, ready to invest more in precision T cell therapies

Cancer Research UK’s spinout, Achilles Therapeutics plc (‘Achilles’), has raised $175.5 million through the closing of its initial public offering (IPO). Cancer Research UK’s spinout, Achilles Therapeutics plc (‘Achilles’), has raised $175.5 million through the closing of its initial public offering (IPO).

18 May 2021

• For Researchers

Mitochondrial DNA in cancer: small genome, big impact

Payam Gammage believes understanding the mutations in mtDNA could reveal indicators of cancer prognosis and a new focus for therapeutics. Payam Gammage believes understanding the mutations in mtDNA could reveal indicators of cancer prognosis and a new focus for therapeutics.

5 May 2021

• Health & Medicine

Vaping: what we know and what we don’t about e-cigarettes

It’s been a decade since e-cigarettes, or vapes, first gained popularity in the UK. And as the popularity levels of e-cigarettes grew, so did the debate around them. It’s been a decade since e-cigarettes, or vapes, first gained popularity in the UK. And as the popularity levels of e-cigarettes grew, so did the debate around them.

26 April 2021

• Charity News

Cancer Research UK appoints Bayo Adelaja as new Trustee 

Responsible for setting the Charity’s strategic direction, Cancer Research UK’s Council of Trustees plays a vital role in setting the organisation's agenda. Responsible for setting the Charity’s strategic direction, Cancer Research UK’s Council of Trustees plays a vital role in setting the organisation's agenda.

23 April 2021

• Science & Technology
• Health & Medicine

Cytosponge-AI combo could help doctors diagnose Barrett’s oesophagus

Cancer Research UK-funded researchers have developed a tool to help experts diagnose a condition that can increase the risk of developing oesophageal cancer. Cancer Research UK-funded researchers have developed a tool to help experts diagnose a condition that can increase the risk of developing oesophageal cancer.

15 April 2021

• Health & Medicine

Liver cancer rates in the UK are highest amongst men in Scotland

A new study has has revealed the variation in the number of people being diagnosed with liver cancer across the UK. A new study has has revealed the variation in the number of people being diagnosed with liver cancer across the UK.

9 April 2021